Sridhar has expressed his intention to take early retirement and has tendered his resignation, the company said in a regulatory filing.
ICICI Direct recommended hold rating on Pfizer with a target price of Rs 4480 in its research report dated August 06, 2022.
US President Joe Biden tested positive for COVID-19 on July 21. He is experiencing mild symptoms and will continue working, the White House said.
The research will focus on prevention, treatment and management of diseases that are of public health priority in India such as cancer and cardiovascular diseases
On Wednesday, a panel of FDA advisers unanimously recommended that the agency approve COVID-19 vaccinations from Moderna Inc and Pfizer Inc/BioNTech SE for millions of youngsters in the United States.
Pfizer previously signalled it would seek to sell its shareholding in Haleon, the world's largest consumer health business and home to Sensodyne toothpaste and Advil painkillers.
US pharmaceutical giant Pfizer on Wednesday said it would sell its patented drugs at a not-for-profit basis to the world's poorest countries, as part of a new initiative announced at the World Economic Forum in Davos.
ICICI Direct recommended hold rating on Pfizer with a target price of Rs 4810 in its research report dated May 23, 2022.
Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial.
The companies said the vaccine was safe and well-tolerated by the children, and they plan to soon ask global regulators to authorize the shot for the age group, children for whom no vaccine is currently approved in most of the world.
Pfizer and its partner BioNTech currently make the only COVID-19 vaccine available for children of any age in the U.S. Those ages 5 to 11 receive a dose that’s one-third the amount given to everyone 12 and older.
The authorization makes everyone in the United States aged five and above eligible for booster doses of the vaccine.
The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received Pfizer as a third dose.
The deal, announced on Tuesday, will give Pfizer access to Biohaven's approved rimegepant, a potential blockbuster that belong to a class of migraine treatments known as calcitonin gene-related peptide (CGRP) inhibitors.
The centre, the first in Asia, will be a part of a network of 12 such facilities to be set up worldwide
The centre, which employs 250 scientists and technicians, would develop innovative formulations, small molecules and active pharmaceutical ingredients (APIs).
The major American drugmaker reported revenues of $25.7 billion for the first quarter, up 77 percent from the year-ago period, with the COVID vaccine taking in $13.2 billion.
Late-stage clinical trials showed Paxlovid cut hospitalisation and death risks in mild to moderately high-risk COVID-19 patients by up to 88 percent and new evidence is emerging that it is also dramatically effective in treating long COVID symptoms
Other CEOs involved with the initiative include Apple's Tim Cook, Adobe's Shantanu Narayen, Bank of America's Brian Moynihan, Microsoft's Brad Smith and Pfizer's Albert Bourla.
Over the past few years, the company has been on a journey to reshape itself into a more growth-oriented and innovative biopharma company, Pfizer said in a regulatory filing.
Protection against severe illness did not wane during the six weeks after the dose but more follow-up study was needed to evaluate its longer-term protection, the researchers said.
Researchers from the New York State Department of Health and the University at Albany School of Public Health, US, estimated the effectiveness of Pfizer vaccine against COVID cases and hospitalisations.
The Korea Disease Control and Prevention Agency reported a record 171,452 new virus cases on Wednesday, nearly a 40-fold increase from levels in mid-January when omicron first emerged as the country’s dominant strain.